A Phase 3 Study of ARO-APOC3 / VSA001 / SAR449124 (Plozasiran) in Chinese Adults With Familial Chylomicronemia Syndrome

NCT05902598 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Chylomicronemia Syndrome

Interventions

DRUG: Plozasiran
DRUG: Placebon

Sponsor

Visirna Therapeutics HK Limited

Collaborators

[object Object]